Dual inhibition of intercellular adhesion molecule-1 and nucleolin reduces RSV infection efficiency in human

Abeer Keshta1, Rina Hashimoto2, Yuki Kitai3

  • 1Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto 606-8507, Japan.

Insights

Respiratory syncytial virus (RSV) infection in infants and older adults is a major concern. This study reveals that intercellular adhesion molecule-1 (ICAM-1) and nucleolin (NCL) are key host factors facilitating RSV infection.

Area of Science:

  • Virology
  • Immunology
  • Cell Biology

Background:

  • Respiratory syncytial virus (RSV) causes significant lower respiratory tract infections, especially in vulnerable populations.
  • Host factors mediating RSV infection are not well understood.
  • Four host surface proteins (ICAM-1, EGFR, NCL, IGF1R) are hypothesized to interact with the RSV fusion (F) protein.

Purpose of the Study:

  • To investigate the roles of ICAM-1, EGFR, NCL, and IGF1R in RSV infection using a human iPSC-derived respiratory organoid model.
  • To determine the impact of suppressing these host factors on viral replication and protein expression.

Main Methods:

  • Utilized human induced pluripotent stem cell (iPSC)-derived respiratory organoids as a model for RSV infection.
  • Genetically depleted ICAM-1 and EGFR using CRISPR-Cas9.
  • Inhibited NCL and IGF1R using neutralizing antibodies.

Main Results:

  • Suppression of ICAM-1 or NCL significantly reduced RSV nucleoprotein gene expression.
  • Inhibition of EGFR or IGF1R showed no significant effect on viral gene expression.
  • Combined suppression of ICAM-1 and NCL led to a greater reduction in infectious viral titers and RSV F protein expression compared to single-protein inhibition.

Conclusions:

  • ICAM-1 and NCL are identified as important host factors in RSV infection within the studied organoid model.
  • Targeting ICAM-1 and NCL may offer a potential therapeutic strategy for RSV.
  • The iPSC-derived respiratory organoid model provides a relevant platform for studying RSV-host interactions.

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...